Almirall, S.A.
Research Almirall, S.A. (ALM.MC) on Bullrun: market cap EUR 2.22B, P/E 36.5, dividend yield 1.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALM.MC
- ExchangeMC
- CountrySpain
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 2.22B
- P/E36.5
- Dividend yield1.9%
- Financial periodQ2 2026
- RevenueEUR 310.32M
- Net incomeEUR 24.25M
- Free cash flowEUR 5.04M
- Gross margin185.1%
Valuation Snapshot
latest market cap is EUR 2.22B; P/E is 36.5; dividend yield is 1.9%.
Peer valuation comparison
Latest P/E is 36.5x versus a Healthcare sector median of 24.61x (48.3% above).
Latest dividend yield is 1.9% versus a Healthcare sector median of 1.84% (3.3% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-04 | EUR 2.22B | 36.5 | 1.8% | 0.19 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.19 EUR, yield 1.9%.
About Almirall, S.A.
Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Almirall, S.A.'s market cap?
Almirall, S.A.'s market capitalization is EUR 2.22B.
What is Almirall, S.A.'s P/E ratio?
Almirall, S.A.'s price-to-earnings (P/E) ratio is 36.5.
Does Almirall, S.A. pay a dividend?
Almirall, S.A. has a dividend yield of 1.9%.
What does Almirall, S.A. do?
Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.